Stay updated on Nivolumab Dose Optimization Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Dose Optimization Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Dose Optimization Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T01:40:34.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says some content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).
    Difference
    1%
    Check dated 2026-10-25T01:41:20.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T01:28:00.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The error page footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T01:51:44.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    An error page (403 Forbidden) is displayed for the study URL, replacing expected content with a 403 screen that includes a Home link and a revision notice, signaling restricted access rather than updated study information.
    Difference
    18%
    Check dated 2026-09-20T00:57:58.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now lists related topics: Lung cancer and MedlinePlus Genetics. These entries connect the trial to broader cancer topics and a genetics information resource.
    Difference
    0.1%
    Check dated 2026-09-12T23:36:15.000Z thumbnail image

Stay in the know with updates to Nivolumab Dose Optimization Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Dose Optimization Clinical Trial page.